2Kolls JK,Linden A.Interleukin-17 family members and inflammation[J].Immunity,2004,21(4):467-476.
3Rho J,Takami M,Choi Y,et al Osteoimmunology:interactions of the immune and skeletal systems[J].Mol Cells,2004,17(1):1-9.
4Chabaud M,Lubberts E,Joosten L,et al.IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis[J].Arthritis Res,2001,3(3):168-177.
5Benchetrit F,Ciree A,Vives V,et al.Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism[J].Blood,2002,99(6):2114-2121.
6Harrington LE,Hatton RD,Mangan PR,et al.Interleukin 17-producing CD4+ effector T cells develop via a liesge distinct from the T helper type 1 and lineages[J].Nat Immunol,2005,6(11):1123-1132.
7Park H,Li ZX,Yang XO,et al.A distinct lieage of CD4 T cells regulates tissue inflammation by producing interleukin 17[J].Nat Immunol,2005,6(11):1133-1141.
8Bettelli E,Carrier Y,Gao W,et al.Reciprocal developmental pathways for the generation of pathogenic effect or TH17 and regulatory T cells[J].Nature,2006,441(7090):235-238.
9Moseley TA,Haudenschild DR,Rose L,et al.Interleukin-17 family and IL-17 receptors[J].Cytokine growth Factor Rev,2003,14(2):155-174.
10Laan M,Lotvall J,Chung KF,et al.IL-17-induced cytokine release in human bronchial epithelial cells in vitro:role of mitogen-activated protein (MAP) kinases[J].Br J Pharmacol,2001,133(1):200-206.
